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We aimed to analyze the antimicrobial resistance phenotypes and to elucidate the
molecular mechanisms underlying resistance to cephalosporins, ciprofloxacin, and
azithromycin in Salmonella enterica serovar Typhimurium isolates identified from patients
with diarrhea in Shanghai. The isolates showed high rates of resistance to traditional
antimicrobials, and 20.6, 12.7, and 5.5% of them exhibited decreased susceptibility
to cephalosporins, ciprofloxacin, and azithromycin, respectively. Notably, 473 (84.6%)
isolates exhibited multidrug resistance (MDR), including 161 (28.8%) isolates that
showed an ACSSuT profile. Twenty-two MDR isolates concurrently exhibited decreased
susceptibility to cephalosporins and ciprofloxacin, and six of them were co-resistant
to azithromycin. Of all the 71 isolates with decreased susceptibility to ciprofloxacin, 65
showed at least one mutation (D87Y, D87N, or D87G) in gyrA, among which seven
isolates simultaneously had mutations of parC (S80R) (n = 6) or parC (T57S/S80R)
(n = 1), while 49 isolates with either zero or one mutation in gyrA contained plasmid-
mediated quinolone resistance (PMQR) genes including qnrB, qnrS, and aac(6′)-Ib-cr.
Among the 115 cephalosporin-resistant isolates, the most common ESBL gene was
blaCTX-M, followed by blaTEM-1, blaOXA-1, and blaSHV-12. Eight subtypes of blaCTX-M were
identified and blaCTX-M-14 (n = 22) and blaCTX-M-55 (n = 31) were found to be dominant.
To the best of our knowledge, this is the first report of the presence of blaCTX-M-123
and blaCTX-M-125 in S. Typhimurium. Besides, mphA gene was identified in 15 of the
31 azithromycin-resistant isolates. Among the 22 isolates with reduced susceptibility to
cephalosporins and ciprofloxacin, 15 contained ESBL and PMQR genes. Coexistence
of these genes lead to the emergence of MDR and the transmission of them will pose
great difficulties in S. Typhimurium treatments. Therefore, surveillance for these MDR
isolates should be enhanced.
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INTRODUCTION
Salmonella infection is a major global public health problem,
which has caused food-borne illnesses in many countries. Data
from the Foodborne Diseases Active Surveillance Network
(Foodnet) report showed that Salmonella has become a leading
cause of death as a food-borne bacterial pathogens in the United
States (Barton Behravesh et al., 2011). Among the more than 2500
serotypes of Salmonella (Popoff et al., 2001), S. Typhimurium
is one of the predominant serotypes in many developed and
developing countries, and the global outbreak of food-borne
diseases due to infection by S. Typhimurium is impressive.
S. Typhimurium infection was very common in the United States;
for example, S. Typhimurium enteritis had been diagnosed in
600 persons in 44 states due to peanut butter contamination in
2008 (Maki, 2009). S. Typhimurium infection has also been often
reported in China and was found to be the second most prevalent
serotype (Ran et al., 2011).
Antimicrobial treatment is needed for infants, the elderly,
and immunocompromised individuals with Salmonella infection.
Fluoroquinolones and cephalosporins are the primary choice for
clinical treatment (Glynn et al., 1998). In addition, azithromycin
has gained the approval of the Food and Drug Administration
(FDA) as an additional agent to treat Salmonella infections
(Sjolund-Karlsson et al., 2011). With the extensive use of such
antimicrobials, antimicrobial resistance is increasing at a serious
rate in Salmonella isolates. In many countries, more and more
Salmonella strains with MDR (defined as resistance to three
or more classes of antimicrobials) have been discovered since
the 1990’s report of the spread of MDR in S. Typhimurium
of definitive phage type 104 (DT104) in the world (Molbak
et al., 1999). Relevant monitoring data showed that MDR in
the entire Salmonella genus has increased from 20 to 30% in
the early 1990s to 70% at the beginning of this century (Su
et al., 2004). S. Typhimurium has also been found to show
high rates of resistance to the traditional antimicrobials, and
resistance to ciprofloxacin or cephalosporins have been found
to have emerged in countries such as France and the United
States (Weill et al., 2006; Whichard et al., 2007). A mass of
S. Typhimurium isolates were also found to be resistant to
ciprofloxacin or cephalosporins in many cities of China (Cui
et al., 2008; Jiang et al., 2014). In recent years, some cases of
azithromycin- resistance in patients with Salmonella infection
were reported (Sjolund-Karlsson et al., 2011). Surprisingly, two
strains have even been reported to be concurrently resistant to
ciprofloxacin, cephalosporins, and azithromycin in China (Wong
et al., 2014).
Shanghai is an economic and financial center located in
eastern China and is divided into 16 administrative units with
more than 24 million people. In order to better monitor
public health issues, the Shanghai Center for Disease Control
and Prevention (SCDC) became a member of the World
Health Organization Global Food-borne Infections Network
(WHO-GFN) in 2005 (Zhang et al., 2014). In this study,
we aimed to analyze the antimicrobial resistance profiles
of S. Typhimurium in Shanghai from 2011 to 2014 and
tried to elucidate the molecular mechanisms underlying the
emergence of MDR in these isolates. Our findings highlight
the importance of increasing surveillance on these isolates
with MDR, which will help provide appropriate clinical
antimicrobial treatment for patients with S. Typhimurium
infection.
MATERIALS AND METHODS
Specimen Collection and Isolate
Identification
Fresh stool samples from clinically suspected patients who
had diarrhea were collected from 24 sentinel hospitals and
eight regional SCDC diagnostic laboratories in Shanghai as
described previously (Zhang et al., 2014). The stool samples were
then enriched in Selenite Brilliant Green broth (CHROMagar,
China) for 16–22 h at 37◦C. The enriched samples were then
cultivated on Salmonella-Shigella (SS) agar or xylose lylose
deoxycholate agar (XLD; CHROMagar, China) and incubated
for 18–24 h at 37◦C. Presumptive colonies were screened by
testing in triple-sugar-iron agar, motility indole urea agar,
L-lysine decarboxylase, and L-galactosidase (o-nitrophenyl-
L-D-galactopyranoside; ONPG). One presumptive colony
from each sample was stored in semisolid agar and sent to
our laboratory for further confirmation. API 20E test strips
(bioMerieux Vitek, Marcy-l’Etoile, France) were used to confirm
the identity of the isolates. All the isolates were then serotyped by
slide agglutination with commercial antiserum (S&A Reagents
Laboratory, Thailand) according to the Kauffmann-White
scheme (World Health Organization, 2011). This study was
approved by Institute of Disease Control and Prevention,
Academy of Military Medical Sciences (Beijing, China) and the
informed consent was obtained from the subjects involved in
this study.
Antimicrobial Susceptibility Testing
The minimum inhibitory concentrations (MICs) for 14
antimicrobial agents including cefoxitin (FOX), ceftriaxone
(CRO), ceftiofur (XNL), azithromycin (AZI), chloramphenicol
(CHL), tetracycline (TET), ciprofloxacin (CIP), gentamicin
(GEN), nalidixic acid (NAL), sulfisoxazole (FIS), ampicillin
(AMP), streptomycin (STR), amoxicillin/clavulanic acid at
a 2:1 ratio (AUG2), and trimethoprim/sulfamethoxazole
(SXT) were evaluated by broth microdilution using the
Sensititre plate CMV3AGNF (Sensititre, Thermo Fisher
Scientific, USA) according to the recommendations of
the Clinical and Laboratory Standards Institute (CLSI)
(Clinical Laboratory Standards Institute, 2016). An
Escherichia coli ATCC 25922 strain was used for quality
control.
PCR Amplification and DNA Sequencing
All the cephalosporin-resistant isolates were analyzed using PCR
assays for the presence of extended-spectrum β-lactamase (ESBL)
genes such as blaCTX-M groups, blaOXA, blaTEM, blaSHV, and
blaCMY (Hasman et al., 2005; Weill et al., 2006; Cui et al., 2015).
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PCR amplification of quinolone resistance-determining regions
(QRDRs) of gyrA, gyrB, parC, and parE (Giraud et al., 1999) and
plasmid-mediated quinolone resistance (PMQR) determinants
[qnrA, qnrB, qnrD, qnrS, and aac(6′)-Ib-cr] (Park et al.,
2006; Cui et al., 2015) were performed on the ciprofloxacin-
resistant or intermediate resistant isolates. All azithromycin-
resistant isolates were subjected to PCR to detect macrolide-
resistance genes including mphA, mphB, ermA, ermB, ereA,
mefA, and msrA (Phuc Nguyen et al., 2009). The primers
used for the above mentioned PCR amplifications are shown
in Table 1. All the PCR products were sequenced by the
Beijing Genomics Institute (BGI). Sequences data were then
analyzed by DNAstar (DNAstar Inc., Madison, WI, USA) and the
sequences were compared with reference sequences from NCBI
GenBank.
Statistical Analysis
Chi-squared test was used for data analysis using SPSS software
(SPSS Inc., Chicago, IL, USA; version 17.0); a P-value < 0.05 was
considered to indicate statistical significance.
RESULTS
S. Typhimurium Isolates from Human
Patients in Shanghai, China, from 2011 to
2014
Between January 2011 and December 2014, 559 S. Typhimurium
isolates were cultured from patients with diarrhea in
Shanghai, China. The age of the patients ranged from
10 days to 86 years (19 cases unknown) (Figure 1). Children
under 5 years of ages, and especially less than 1-year-old
children, were highly susceptible to S. Typhimurium
infection, which accounted for 49.4% of all the patients
(P < 0.05). The ratio of the male to female patients was
1.3:1. Infections occurred mainly in summer and autumn
(Figure 1).
Antimicrobial Susceptibility Testing
Among the 559 isolates, only 26 (4.7%) were susceptible to all 14
antimicrobials. Resistance to tetracycline was the most common
(83.7%), followed by ampicillin (80.1%), nalidixic acid (79.2%),
sulfisoxazole (77.1%), chloramphenicol (54.9%), streptomycin
(53.7%), trimethoprim/sulfamethoxazole (47.4%), gentamicin
(37%), and amoxicillin/clavulanic acid (7.9%) (Table 2). In
addition, resistance to ceftiofur, ceftriaxone, and cefoxitin was
found in 20, 20, and 5% of isolates, respectively. Notably, 3.6%
(20/599) of the isolates displayed resistance (MIC ≥ 4 µg/mL)
to ciprofloxacin, and 9.1% (51/599) exhibited intermediate
resistance to ciprofloxacin (MICs= 2µg/mL). More importantly,
22 of the isolates showed co-resistance to cephalosporins.
Moreover, 31 (5.5%) isolates were showed resistance to
azithromycin, and 6 of them were co-resistant to cephalosporins
and ciprofloxacin.
Multidrug resistance was observed in 84.6% of the isolates,
in which ≥3, ≥4, ≥5, ≥6, and ≥7 classes of antimicrobials
were found in 84.6, 77.8, 61, 38.5, and 1.1% of the MDR
isolates, respectively. Among the MDR isolates, 161 (28.8%)
showed the ACSSuT resistance pattern (defined as resistance
to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole,
and tetracycline); among them, 40 (7.2%) isolates exhibited
reduced susceptibility to ciprofloxacin, 36 (6.4%) were resistant to
cephalosporins, and 10 (1.8%) were resistant to azithromycin. It is
noteworthy that 6 (1.1%) isolates with ACSSuT resistance pattern
were concurrently resistant to ciprofloxacin and cephalosporins,
and one of them was also co-resistant to azithromycin (Table 2).
PCR Detection of Antimicrobial Drug
Resistance Genes and DNA Sequencing
Resistance genes including blaOXA, blaTEM, blaSHV, blaCMY, and
blaCTX-M in the 115 cephalosporin-resistance isolates were
detected by PCR. PCR screenings revealed that 75
(65.2%), 52 (45.2%), 43 (37.4%), and 3 (2.6%) isolates
contained the blaCTX, blaTEM, blaOXA, and blaSHV genes,
respectively. All the strains were negative for blaCMY.
Fifty-two isolates contained two of the above described
genes (blaCTX-M+blaTEM/blaCTX-M+blaOXA/blaTEM+blaSHV),
and nine isolates concurrently contained blaCTX-M, blaTEM, and
blaOXA. Sequencing of the PCR products revealed that blaTEM-1,
blaOXA-1, and blaSHV-12 were the main genotypes. blaCTX-M
included eight subtypes: blaCTX-M-14, blaCTX-M-15, blaCTX-M-27,
blaCTX-M-55, blaCTX-M-65, blaCTX-M-104, blaCTX-M-123, and
blaCTX-M-125, among which blaCTX-M-14 and blaCTX-M-55 were
the most common subtypes (Figure 2).
We identified 71 isolates with decreased susceptibility to
ciprofloxacin, and 65 of them contained at least one gyrA
mutation which mainly occurred at encode 87 (D87Y, D87N,
or D87G). Among them, six had double mutations (S83F/D87N
or D87G) in the gyrA gene and a single mutation (S80R) in
the parC gene; 1 isolate with four mutations, including two in
gyrA gene (S83F/D87N) and two in parC gene (T57S/S80R);
58 isolates with only one gyrA mutation (D87Y or D87N).
No point mutations in gyrB and parE were found. Here, three
species of PMQR determinants including aac(6′)-Ib-cr (n = 50),
qnrB (qnrB2, n = 2; qnrB4, n = 4), and qnrS1 (n = 1) were
detected. Among the 49 isolates with no mutation or only one
mutation in gyrA gene, one or two PMQR genes were detected
(Table 3).
In addition, PCR results showed that 15 out of the 31
azithromycin-resistant isolates (MIC ≥ 128 µg/mL) harbored
mphA genes, while the other 16 (MIC: 16–64 µg/mL) did not.
All the azithromycin-resistant isolates were negative for mphB,
ermA, ermB, ereA, mefA, and msrA.
Notably, among the 22 isolates that concurrently
exhibited reduced susceptibility to cephalosporins and
ciprofloxacin, 15 contained ESBL and PMQR genes. Two
isolates contained four types of antimicrobial-resistance genes:
qnrB/aac(6′)-Ib-cr/blaCTX-M/blaTEM (n = 1) and aac(6′)-Ib-
cr/blaOXA/blaCTX-M/blaTEM (n = 1). Nine isolates harbored
three types of antimicrobial resistant genes, including qnrB
/aac(6′)-Ib-cr/blaOXA (n = 2), aac(6′)-Ib-cr/blaOXA/blaCTX-M
(n = 4), and aac(6′)-Ib-cr/blaCTX-M/blaTEM (n = 3). Four
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TABLE 1 | Primers for the PCR detection of antimicrobal-resistance determinants.
Target Primer sequence (5′–3′) Amplicon size (bp) Reference
β-Lactamases
blaCTX-M-1 group F:GGTTAAAAAATCACTGCGTC 873 Cui et al., 2015
R:TTACAAACCGTCGGTGACGA
blaCTX-M-9 group F:AGAGTGCAACGGATGATG 868 Cui et al., 2015
R:CCAGTTACAGCCCTTCGG
blaCTX−M−2/8/25 group F:ACCGAGCCSACGCTCAA 221 Cui et al., 2015
R:CCGCTGCCGGTTTTATC
blaOXA-1 group F:ATGAAAAACACAATACATATC 830 Weill et al., 2006
R:AATTTAGTGTGTTTAGAATGG
blaTEM F:ATAAAATTCTTGAAGACGAAA 1080 Weill et al., 2006
R:GACAGTTACCAATGCTTAATC
blaSHV F:TTATCTCCCTGTTAGCCACC 795 Weill et al., 2006
R:GATTTGCTGATTTCGCTCGG
blaCMY F:GTGGTGGATGCCAGCATCC 915 Hasman et al., 2005
R:GGTCGAGCCGGTCTTGTTGAA
QRDR of Topoisomerase genes
gyrA F: TGGGCAATGACTGGAACA 431 This study
R: GGTTGTGCGGCGGGATA
gyrB F: ATGAGCGATATGGCAGAGCG 309 Cui et al., 2015
R:GCTGTGATAACGCAGTTTGTCCGGG
parC F:ATGAGCGATATGGCAGAGCG 413 Giraud et al., 1999
R:TGACCGAGTTCGCTTAACAG
parE F:ATGCGTGCGGCTAAAAAAGTG 290 Cui et al., 2015
R:TCGTCGCTGTCAGGATCGATAC
PMQR
qnrA F:ATTTCTCACGCCAGGATTTG 516 Cui et al., 2015
R:GATCGGCAAAGGTTAGGTCA
qnrB F:GATCGTGAAAGCCAGAAAGG 469 Cui et al., 2015
R:ACGATGCCTGGTAGTTGTCC
qnrD F:CGAGATCAATTTACGGGGAATA 656 Cui et al., 2015
R:AACAAGCTGAAGCGCCTG
qnrS F:ACGACATTCGTCAACTGCAA 417 Cui et al., 2015
R:TAAATTGGCACCCTGTAGGC
aac(6′)-Ib-cr F:TTGCGATGCTCTATGAGTGGCTA 482 Park et al., 2006
R:CTCGAATGCCTGGCGTGTTT
Macrolide-resistance Genes
mphA F:GTGAGGAGGAGCTTCGCGAG 403 Phuc Nguyen et al., 2009
R:TGCCGCAGGACTCGGAGGTC
mphB F:GATATTAAACAAGTAATCAGAATAG 494 Phuc Nguyen et al., 2009
R:GCTCTTACTGCATCCATACG
ermA F:TCTAAAAAGCATGTAAAAGAAA 533 Phuc Nguyen et al., 2009
R:CGATACTTTTTGTAGTCCTTC
ermB F:GAAAAAGTACTCAACCAAATA 693 Phuc Nguyen et al., 2009
R:AATTTAAGTACCGTTACT
ereA F:GCCGGTGCTCATGAACTTGAG 420 Phuc Nguyen et al., 2009
R:CGACTCTATTCGATCAGAGGC
mefA F:AGTATCATTAATCACTAGTGC 345 Phuc Nguyen et al., 2009
R:TTCTTCTGGTACTAAAAGTGG
msrA F:GCACTTATTGGGGGTAATGG 384 Phuc Nguyen et al., 2009
R:GTCTATAAGTGCTCTATCGTG
isolates contained two types of antimicrobial-resistant genes:
aac(6′)-Ib-cr/blaTEM (n = 2) and aac(6′)-Ib-cr/blaCTX-M
(n = 2). In addition, 2 out of the 15 isolates that were
co-resistant to azithromycin concurrently harbored ESBL,
PMQR, and mphA genes: aac(6′)-Ib-cr/blaCTX-M/blaTEM/mphA
(Table 4).
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FIGURE 1 | Distribution of human S. Typhimurium isolates in patients by (A) age and (B) months (2011–2014) in Shanghai, China.
TABLE 2 | Antimicrobial resistance of S. Typhimurium isolates in Shanghai from 2011 to 2014.
N (%) of resistant isolates
2011 (N = 77) 2012 (N = 155) 2013 (N = 167) 2014 (N = 160) Total (N = 559)
Pan-susceptible 4 (5.2) 8 (5.2) 4 (2.4) 10 (6.3) 26 (4.7)
Nalidixic Acid 67 (87) 107 (60) 145 (86.8) 124 (77.5) 443 (79.2)
Ciprofloxacin 7 (9.1) 4 (2.6) 6 (3.6) 3 (1.9) 20 (3.6)
Ampicillin 54 (70.1) 124 (80) 150 (89.8) 120 (75) 448 (80.1)
Ceftiofur 23 (29.9) 37 (23.9) 30 (18) 22 (13.8) 112 (20)
Cefoxitin 8 (10.4) 17 (10.3) 1 (0.6) 2 (3.8) 28 (5)
Ceftriaxone 23 (29.9) 37 (23.9) 30 (18) 22 (13.8) 112 (20)
Tetracycline 58 (75.3) 124 (80) 156 (93.4) 130 (81.3) 468 (83.7)
Streptomycin 33 (42.9) 74 (47.7) 97 (58.1) 96 (60) 300 (53.7)
Gentamicin 29 (37.7) 62 (40) 81 (48.5) 35 (21.9) 207 (37)
Chloramphenicol 31 (40.3) 86 (55.5) 124 (74.3) 66 (41.3) 307 (54.9)
Azithromycin 1 (1.3) 13 (8.4) 4 (2.4) 13 (8.1) 31 (5.5)
Sulfisoxazole 27 (35.1) 126 (81.3) 156 (93.4) 122 (76.3) 431 (77.1)
trimethoprim/sulfamethoxazole 31 (40.3) 76 (49) 97 (58.1) 61 (38.1) 265 (47.4)
amox-icillin/clavulanic acid 9 (11.7) 20 (12.9) 5 (3) 10 (6.3) 44 (7.9)
MDR pattern
≥3 antimicrobials 56 (72.7) 130 (83.9) 159 (95.2) 128 (80) 473 (84.6)
≥4 antimicrobials 51 (66.2) 121 (78.1) 147 (88) 116 (72.5) 435 (77.8)
≥5 antimicrobials 40 (51.9) 91 (58.7) 125 (74.9) 85 (53.1) 341 (61)
≥6 antimicrobials 25 (32.5) 52 (33.5) 91 (54.5) 47(29.4) 215 (38.5)
≥7 antimicrobials 1 (1.3) 0 (0) 1 (0.6) 4 (2.5) 6 (1.1)
ACSSuT 15 (19.5) 42 (27.1) 66 (39.5) 38 (23.8) 161 (28.8)
ACSSuT+CIP 5 (6.5) 6 (3.9) 18 (10.8) 11 (6.9) 40 (7.2)
ACSSuT+CEP 7 (9.1) 15 (9.7) 8 (4.8) 6 (3.8) 36 (6.4)
ACSSuT+AZI 1 (1.3) 2 (1.3) 1 (0.6) 6 (3.8) 10 (1.8)
ACSSuT+CIP+CEP 2 (2.6) 0 (0) 2 (1.2) 2 (1.3) 6 (1.1)
ACSSuT+CIP+CEP+AZI 1 (0.2) 0 (0) 0 (0) 0 (0) 1 (0.2)
CIP, Ciprofloxacin; CEP, cephalosporins; AZI, Azithromycin.
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FIGURE 2 | The CTX-M proportions of cephalosporin-resistant S. Typhimurium isolates. The digit before “;” indicates the number of isolates that contained
blaCTX-M genes, and the digit after “;” indicates the percentage of isolates that contained blaCTX-M genes.
TABLE 3 | Distribution of PMQR genes and mutations in gyrA, gyrB, parC, and parE genes in S. Typhimurium isolates with decreased susceptibility to
ciprofloxacin in Shanghai, China.
QRDR mutation PMQR N Total
gyrA gyrB parC parE I∗ R∗∗
WT WT WT WT qnrS 1 0 1
WT WT WT WT aac(6′)-Ib-cr 1 0 1
WT WT WT WT aac(6′)-Ib-cr,qnrB 1 3 4
D87Y WT WT WT WT 15 0 15
D87Y WT WT WT aac(6′)-Ib-cr 20 4 24
D87N WT WT WT aac(6′)-Ib-cr 13 4 17
D87Y WT WT WT aac(6′)-Ib-cr,qnrB 0 2 2
S83F/D87N WT S80R WT WT 0 4 4
S83F/D87N WT S80R WT aac(6′)-Ib-cr 0 1 1
S83F/D87G WT S80R WT WT 0 1 1
S83F/D87N WT T57S/S80R WT aac(6′)-Ib-cr 0 1 1
∗S. Typhimurium isolates with intermediate resistance to CIP (MIC = 2 µg/mL); ∗∗S. Typhimurium isolates with resistance to CIP (MIC ≥ 4 µg/mL); WT, wild type.
DISCUSSION
In present study, we found that S. Typhimurium isolates in
Shanghai, China, exhibited high rates of resistance to traditional
antimicrobials, such as tetracycline, ampicillin, nalidixic acid,
and sulfisoxazole. Moreover, resistance to cephalosporins,
ciprofloxacin and azithromycin were found in 20.6, 3.6, and
5.5% of the isolates, respectively. Contradictory to this result
from the current study, the report of the NARMS indicated that
the number of cephalosporin-resistant, ciprofloxacin-resistant
and azithromycin-resistant isolates was lower than 6, 1, and
1% (2011–2014), respectively (Centers for Disease Control and
Prevention, 2016). More importantly, 84.6% of the isolates were
found to exhibit MDR in our study, which is significantly
higher than the percentage observed from the surveillance
data during 2005 to 2010 in Shanghai and that indicated in
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TABLE 4 | Summary of phenotypes of S. Typhimurium isolates showing concurrently decreased susceptibility to ciprofloxacin and cephalosporins and
their corresponding resistance genes.
Strain MIC (µg/mL) QRDR mutation PMQR ESBL mphA
FOX CRO XNL CIP AZI gyrA parC
SHI 1G663 >32 4 8 4 4 WT WT qnrB/aac(6′)-Ib-cr
SHI 1G664 >32 8 >8 4 2 WT WT qnrB/aac(6′)-Ib-cr blaOXA
SHI 1G665 >32 32 8 4 4 WT WT qnrB/aac(6′)-Ib-cr blaOXA
SH11G680 4 >64 >8 >4 2 S83F/D87N S80R blaOXA/blaCTX-M-55
SHI 1G993 >32 16 >8 >4 256 S83F/D87N S80R blaOXA mphA
SH11G1304 2 >64 >8 2 4 D87Y WT aac(6′)-Ib-cr blaOXA/blaCTX-M-27
SH11G1306 2 >64 >8 2 4 D87Y WT
SHI 2G734 32 <0.25 2 2 4 D87Y WT aac(6′)-Ib-cr blaTEM
SHI 2G889 32 <0.25 2 4 8 D87Y WT aac(6′)-Ib-cr blaOXA/blaCTX-M-14/blaTEM
SH12G978 32 >64 >8 2 64 WT WT qnrB/aac(6′)-Ib-cr blaCTX-M-15/blaTEM
SHI 2G1005 8 >64 >8 >4 64 S83F/D87N T57S/S80R aac(6′)-Ib-cr blaCTX-M-65/blaTEM
SHI 3G355 2 >64 >8 2 4 D87N WT aac(6′)-Ib-cr blaTEM
SHI 3G769 2 >64 >8 2 4 D87N WT aac(6′)-Ib-cr blaCTX-M-14
SHI 3G938 16 >64 >8 2 4 D87N WT blaOXA/blaCTX-M-55
SHI 3G939 16 >64 >8 2 4 D87N WT blaOXA/blaCTX-M-55
SH13G1219 8 >64 >8 >4 128 D87Y WT aac(6′)-Ib-cr blaCTX-M-15/blaTEM mphA
SHI 3G1825 2 >64 >8 >4 128 D87Y WT aac(6′)-Ib-cr blaCTX-M-15/blaTEM mphA
SHI 4G287 4 >64 >8 2 8 WT WT aac(6′)-Ib-cr blaOXA/blaCTX-M-125
SHI 4G294 8 64 >8 2 8 D87N WT aac(6′)-Ib-cr blaOXA/blaCTX-M-125
SHI 4G300 4 64 >8 2 64 D87N WT aac(6′)-Ib-cr blaOXA/blaCTX-M-125
SHI 4G1345 4 >64 >8 2 4 D87Y WT blaOXA/blaCTX-M-55/blaTEM
SH14G1601 2 >64 >8 2 4 D87N WT aac(6′)-Ib-cr blaCTX-M-55
FOX, cefoxitin; CRO, ceftriaxone; XNL, ceftiofur; CIP, ciprofloxacin; AZI, azithromycin; WT, wild type.
the NARMS report for the same period (P < 0.05) (Zhang
et al., 2014; Centers for Disease Control and Prevention,
2016). Notably, in the current study, we found that 22 MDR
isolates with decreased susceptibility to ciprofloxacin were co-
resistant to cephalosporins. Six of the 22 isolates also showed
resistance to azithromycin. This phenomenon has only been
reported previously in two clinical S. Typhimurium strains
in China (Wong et al., 2014). If these MDR strains are as
prevalent as S. Typhimurium DT104 all over the world, it
will pose a great threat to global public health. Our findings
indicate that it is therefore necessary to continue monitoring
the antimicrobial resistance of S. Typhimurium isolates to help
determine the appropriate antimicrobial therapy for patients with
S. Typhimurium infection. More importantly, it is necessary to
study the mechanisms underlying the antimicrobial resistance in
these isolates.
The main mechanisms of quinolone-resistance in Salmonella
have been attributed to several point mutations in the QRDRs
of the gyrA and parC genes and the PMQR genes (Hopkins
et al., 2007; Kim et al., 2013). Mutations at different sites
contribute to different levels of resistance to ciprofloxacin, and
simultaneous mutations in both gyrA and parC genes produce
high levels of ciprofloxacin resistance. Besides, most isolates
with decreased susceptibility to ciprofloxacin contain a mutation
in gyrA or PMQR genes (Ling et al., 2003; Lin et al., 2015).
In the present study, we found that six isolates had double
mutations (S83F/D87N or D87G) in the gyrA gene and a single
mutation (S80R) in the parC gene. Additionally, one isolate
with four mutations, including two in gyrA gene (S83F/D87N)
and two in parC gene (T57S/S80R). These mutations have
been previously reported to be most common in ciprofloxacin-
resistant S. Typhimurium strains (Wasyl et al., 2014). PMQR was
initially identified in Klebsiella pneumonia in 1998 (Martinez-
Martinez et al., 1998), since then, various types of PMQR genes
have been detected in Salmonella all over the world (Cattoir et al.,
2007; Cavaco et al., 2009; Kim et al., 2013). Previous studies
have shown that the presence of qnr genes increase the MICs
for ciprofloxacin by 8–16-fold (Kim et al., 2013). In addition,
the presence of aac(6′)-Ib-cr genes can increase the selection
of chromosomal mutants that cause ciprofloxacin resistance
(Robicsek et al., 2006). In the current study, we also showed that
the existence of PMQR genes remarkably enhances the MICs
(≥2 µg/mL) of ciprofloxacin in the presence of a single or no
point mutation in the gyrA gene in S. Typhimurium isolates. The
emergence of PMQR genes described in this report has also been
frequently reported previously in Salmonella isolates in other
parts of China (Lu et al., 2011; Jiang et al., 2014; Wong et al.,
2014), which suggests that the PMQR genes have been prevalent
in China.
Since the discovery of blaCTX-M genes in Japan, Europe,
and South America in the 1980s (Matsumoto et al., 1988;
Bauernfeind et al., 1990, 1992), they have quickly replaced blaTEM
and blaSHV as the major ESBL (D’Andrea et al., 2013). In
the present study, of the 115 cephalosporin-resistant isolates,
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62.5% harbored blaCTX-M genes, in which blaCTX-M-55 was the
most common gene, followed by blaCTX-M-14. This phenomenon
proved that the blaCTX-M-1 and blaCTX-M-9 groups are popular
types in S. Typhimurium isolates in Shanghai. Besides, the
subtypes of blaCTX-M-123 and blaCTX-M-125 have also been
identified in E. coli (Rao et al., 2014), but have not been found
in Salmonella. To the best of our knowledge, this study is the
first to report blaCTX-M-123 and blaCTX-M-125 in S. Typhimurium.
In addition, 52 (45.2%), 43 (37.4%), and 3 (2.6%) isolates were
found to contain the blaTEM-1, blaOXA-1, and blaSHV-12 genes,
respectively. Because the ESBL genes are usually located on the
antimicrobial-resistance plasmid of the bacteria, they can be
easily disseminated between different species of bacteria with the
transfer of the drug-resistance plasmid (Arlet et al., 2006).
As the number of cephalosporin-resistant and ciprofloxacin-
resistant Salmonella strains gradually increased, an alternative
antimicrobial class was needed to manage Salmonella infections.
Azithromycin showed excellent ability to accumulating at
high intracellular concentrations, and it achieved intracellular
concentrations of 50 to 100 times greater than the serum
levels (Panteix et al., 1993). Therefore, azithromycin was
recommended for the treatment of invasive Salmonella infections
by the FAD (Sjolund-Karlsson et al., 2011). However, in the
present study, 31(5.5%) isolates were found to be resistant
to azithromycin. Previously, Salmonella strains resistant to
azithromycin have also been found in other countries (Sjolund-
Karlsson et al., 2011; Kalonji et al., 2015). The plasmid-
borne mphA gene was reported as one of the reasons of
azithromycin-resistance (Glynn et al., 1998). In the present
study as well, 15 high-level azithromycin-resistant isolates
(MIC ≥ 128 µg/mL) harbored the mphA gene, while other
16 (MIC: 16–64 µg/mL) did not. All azithromycin-resistant
isolates were negative for mphB, ermA, ermB, ereA, mefA,
and msrA. These results indicate that the mphA gene may
mediate a high level of resistance to azithromycin in Salmonella,
as described previously in Shigella in China (Zhang et al.,
2016). In addition, azithromycin resistance may arise from
other possible mechanisms, such as mutations in the rlpD and
rlpV genes (Roberts, 2008). At present, few studies have been
focused on investigating azithromycin resistance mechanisms in
Salmonella. The findings of the present study and those of other
previous studies emphasize the need for investigating the further
mechanisms underlying azithromycin resistance in Salmonella
isolates.
Antimicrobial-resistance genes are usually located on
plasmids and therefore can be easily disseminated; for example
the ESBL genes often coexist with the genes encoding resistance
to other antimicrobial agents in plasmids, which can easily lead
to a MDR phenotype in ESBL-producing bacteria (Jiang et al.,
2014). In this study, we found that 15 isolates showed both ESBL
and PMQR genes, in which concurrently displayed decreased
susceptibility to cephalosporins and ciprofloxacin. Besides, 2 of
the 15 isolates co-contained mphA genes, which were resistant to
azithromycin.
CONCLUSION
In this study, we reported the common occurrence of MDR
in S. Typhimurium isolates in Shanghai, China. We found that
resistance to ciprofloxacin, cephalosporins, and azithromycin
was most prevalent among the isolates. Among the MDR
isolates, we found various transferrable antimicrobial-resistance
genes, which included ESBL, PMQR and mphA genes, and
some isolates even contained at least two types of these genes.
The dissemination of these genes poses a huge threat to
the control of S. Typhimurium infection in the world. Our
findings indicate that it is imperative to continue monitoring the
prevalence of the above-mentioned three types of antimicrobial
resistance and their resistant genes in S. Typhimurium isolates.
Future studies should be focused on identifying ways to
prevent the dissemination of these antimicrobial-resistance
genes.
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